SU 5416

Catalog # Availability Size / Price Qty
SU 5416 | CAS No. 204005-46-9 | VEGF Receptor Inhibitors
1 Image
Description: VEGFR inhibitor. Also inhibits KIT, RET, MET and FLT3
Alternative Names: Semaxinib

Chemical Name: 3-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-2H-indol-2-one

Purity: ≥99%

Product Details
Citations (12)
Supplemental Products

Biological Activity

Inhibitor of vascular endothelial growth factor receptor (VEGFR) that also inhibits other tyrosine kinases KIT, MET, FLT3 and RET. Displays no activity against EGFR, HER2, IGF1R and PDGFR. Inhibits tumor vascularization and growth of multiple tumor types.

Technical Data

Soluble to 100 mM in DMSO
Desiccate at -20°C

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets

Or select another batch:
Reconstitution Calculator
Molarity Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Molarity Calculator


*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Citations for SU 5416

The citations listed below are publications that use Tocris products. Selected citations for SU 5416 include:

12 Citations: Showing 1 - 10

  1. Amino Acid Restriction Triggers Angiogenesis via GCN2/ATF4 Regulation of VEGF and H2S Production.
    Authors: Longchamp Et al.
    Cell  2018;173:117
  2. TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling.
    Authors: Hurst
    Nat Commun  2017;8:14079
  3. Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension.
    Authors: Meloche Et al.
    Arterioscler Thromb Vasc Biol  2017;37:1513
  4. Chronic Embolic Pulmonary Hypertension Caused by Pulmonary Embolism and Vascular Endothelial Growth Factor Inhibition.
    Authors: Neto-Neves Et al.
    Am J Pathol  2017;187:700
  5. Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.
    Authors: Happ&eacute Et al.
    Am J Physiol Lung Cell Mol Physiol  2016;310:L1088
  6. Desert Hedgehog/Patch2 Axis Contributes to Vascular Permeability and Angiogenesis in Glioblastoma.
    Authors: Azzi Et al.
    Pulm Circ  2015;6:281
  7. Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.
    Authors: Long Et al.
    Nat Med  2015;21:777
  8. Role of vascular endothelial growth factor signaling in Schistosoma-induced experimental pulmonary hypertension.
    Authors: Chabon Et al.
    J Neurophysiol  2014;4:289
  9. KRIT1 protein depletion modifies endothelial cell behavior via increased vascular endothelial growth factor (VEGF) signaling.
    Authors: DiStefano Et al.
    J Biol Chem  2014;289:33054
  10. Effects of the vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor SU5416 on in vitro cultures of Plasmodium falciparum.
    Authors: Hempel Et al.
    Malar J  2014;13:201


No product specific FAQs exist for this product, however you may

View all Small Molecule FAQs

Reviews for SU 5416

There are currently no reviews for this product. Be the first to review SU 5416 and earn rewards!

Have you used SU 5416?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review
Tocris Bioscience is the leading supplier of novel and exclusive tools for life science research with over 30 years' experience in the industry. Tocris is a Bio-Techne brand.